Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
17.36B | 17.72B | 17.60B | 24.70B | 23.10B | 16.21B | Gross Profit |
5.09B | 1.31B | 1.14B | 1.87B | 1.61B | 1.17B | EBIT |
734.07M | 669.14M | 514.61M | 1.27B | 1.08B | 673.27M | EBITDA |
807.40M | 762.26M | 613.59M | 1.36B | 1.17B | 775.00M | Net Income Common Stockholders |
508.09M | 465.69M | 325.13M | 940.52M | 844.25M | 506.42M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
129.94M | 145.76M | 145.52M | 217.48M | 257.41M | 243.80M | Total Assets |
5.23B | 5.30B | 5.23B | 5.95B | 7.03B | 5.14B | Total Debt |
1.73B | 1.74B | 1.95B | 2.36B | 2.23B | 1.43B | Net Debt |
1.60B | 1.60B | 1.81B | 2.14B | 1.97B | 1.18B | Total Liabilities |
3.49B | 3.58B | 3.81B | 4.60B | 5.01B | 3.26B | Stockholders Equity |
1.73B | 1.72B | 1.42B | 1.35B | 2.02B | 1.88B |
Cash Flow | Free Cash Flow | ||||
606.29M | 486.43M | 647.84M | 1.52B | 24.03M | 445.18M | Operating Cash Flow |
648.94M | 509.08M | 731.95M | 1.65B | 94.95M | 499.19M | Investing Cash Flow |
-40.16M | -74.29M | -82.79M | -64.92M | -85.67M | -271.71M | Financing Cash Flow |
-597.00M | -416.10M | -717.83M | -1.62B | 7.57M | -440.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $15.57B | 18.88 | 37.70% | 1.29% | 24.07% | 27.40% | |
70 Outperform | $11.37B | 22.88 | 32.11% | 2.56% | -0.22% | 65.52% | |
68 Neutral | $4.79B | 27.17 | 18.34% | 1.02% | -4.72% | -22.46% | |
65 Neutral | $2.04B | 19.52 | 6.35% | 1.47% | -4.63% | -18.94% | |
65 Neutral | $13.79B | 25.25 | 13.97% | 1.24% | -3.82% | -12.80% | |
64 Neutral | $4.39B | 11.81 | 5.20% | 249.38% | 3.96% | -12.36% | |
64 Neutral | $13.99B | 36.55 | 26.24% | ― | 1.94% | 60.91% |
C.H. Robinson held its 2025 Annual Meeting of Shareholders virtually on May 8, 2025, where approximately 90% of outstanding shares were represented. During the meeting, shareholders elected ten directors for one-year terms, approved executive compensation on a non-binding basis, ratified Deloitte & Touche LLP as the independent accounting firm for 2025, and approved the amended 2022 Equity Incentive Plan.
The most recent analyst rating on (CHRW) stock is a Hold with a $92.00 price target. To see the full list of analyst forecasts on CH Robinson stock, see the CHRW Stock Forecast page.